"10.1371_journal.pone.0013341","plos one","2010-10-11T00:00:00Z","Josefine Friberg; Morten F Tonnesen; Schott Heller; Flemming Pociot; Thóra B Bödvarsdottir; Allan E Karlsen","Diabetes Inflammation, Hagedorn Research Institute, Gentofte, Denmark; Beta-cell Regeneration, Hagedorn Research Institute, Gentofte, Denmark; Hagedorn Research Institute, Gentofte, Denmark; Department of Clinical Sciences, University Hospital MAS, Lund University/CRC, Malmö, Sweden; Diabetes and Obesity Pharmacology Novo Nordisk A/S, Maaloev, Denmark","Conceived and designed the experiments: JF MFT FP TBB AK. Performed the experiments: JF TBB. Analyzed the data: JF MFT SH TBB AK. Contributed reagents/materials/analysis tools: JF. Wrote the paper: JF.","Morten F. Tonnesen, Flemming Pociot, Thóra B. Bödvarsdottir and Allan E. Karlsen are employed by Novo Nordisk A/S. The drug (IKKβ-inhibitor) used in this study is not a Novo Nordisk patent, product in development or marketed product, etc., and it does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2010","10","Josefine Friberg","JF",6,TRUE,5,2,5,1,TRUE,TRUE,FALSE,0,NA,FALSE
